News
Glenmark likely to make anti-viral Favipiravir to treat COVID-19
India’s Glenmark Pharmaceuticals, based in Mumbai, is getting ready to produce Japanese approved anti-viral, Favipiravir in the country to help treatment of COVID-19 patients.
Gilead issues statement on data from Remdesivir study in patients with severe COVID-19 in China
In the statement Gilead’s CMO Merdad Parsey says that the study was terminated early due to low enrollment and, as a result, it was underpowered to enable statistically meaningful conclusions.
